Skip to main content

Table 3 CACS according to FibroTest® stages

From: Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts

Characteristic

Total

FibroTest® stages

P-value for trend

F0

F1

F2

F3-F4

DIACART

 n

157

64

42

22

29

 

 CACS

1035 ± 1039

812 ± 793

885 ± 937

1424 ± 906

1449 ± 1032

0.0009

  0–10, % (n)

9.6 (15)

15.6 (10)

9.5 (4)

4.5 (1)

0.0 (0)

0.011

  > 10–100, % (n)

8.3 (13)

12.5 (8)

4.8 (2)

0.0 (0)

10.3 (3)

0.38

  > 100–400, % (n)

20.4 (32)

18.8 (12)

28.6 (12)

22.7 (5)

10.3 (3)

0.43

  > 400, % (n)

61.8 (97)

53.1 (34)

57.1 (24)

72.7 (16)

79.3 (23)

0.007

ACCoDiab

 n

460

296

92

28

44

 

 CACS

30 [0–211]

16 [0–173]

61 [0–244]

71 [8–314]

151 [0–600]

0.0001

  0–10, % (n)

42.0 (193)

47.6 (141)

31.5 (29)

21.4 (7)

36.4 (16)

0.007

  > 10–100, % (n)

22.6 (103)

22.6 (67)

28.2 (26)

28.6 (8)

6.8 (3)

0.93

  > 100–400, % (n)

18.9 (87)

16.9 (50)

22.8 (21)

25.0 (7)

20.5 (9)

0.62

  > 400, % (n)

16.5 (77)

12.8 (38)

17.4 (16)

21.4 (6)

36.4 (16)

0.049

  1. Data are presented as percentages (n), means ± standard deviations (for normally-distributed variables) or medians [1st—3rd quartiles] (for skewed variables), as appropriate. Bold is used when the p-value < 0.05
  2. CACS coronary artery calcium score, SD standard deviation